The authors examined the relation between family history of prostate cancer and the risk of this cancer in a population-based case-control study conducted in Massachusetts between December 1992 and October 1994. Cases were all incident cases of prostate cancer in men younger than 70 years (n = 563); controls were men with no history of the disease matched to the cases on age and town of residence (n = 703). Prostate cancer risk was increased among men who reported a history of this cancer in either their fathers or brothers (odds ratio (OR) = 2.3, 95% confidence interval (Cl) 1.7-3.3). Risk varied with the number of relatives affected and their relationship to the case. For a history of prostate cancer in one relative, the OR was 2.2 (95% Cl 1.5-3.2); if two or more relatives were affected, it was 3.9 (95% Cl 1.7-5.2). For prostate cancer in the father, the OR was 1.9 (95% Cl 1.2-3.0); for prostate cancer in a brother, it was 3.0 (95% Cl 1.8-^.9). Risk was inversely related to the subject's age and to age at diagnosis of prostate cancer in his affected relative. Among probands younger than 60 years, the OR was 5.3 (95% Cl 2.5-12); for those 60-64 years of age, the OR was 2.7 (95% Cl 1.3-5.5); and for those 65 years of age and older, the OR was 1.6 (95% Cl 1.0-2.5). For prostate cancer diagnosed in a relative before age 65, the OR was 4.1 (95% Cl 2.3-7.3); for detection of the disease after age 74, the OR was 0.76 (95% Cl 0.38-1.5). The association was present both among men with local and advanced stage disease and among men whose prostate cancer was detected either by screening or because of symptoms. These data provide evidence that after controlling for diet and other potential confounders, familial factors are significantly associated with the risk of prostate cancer. Am J Epidemiol 1996;144:1041-7. epidemiologic factors; family; men; prostatic neoplasms; risk factors Prostate cancer is the most common nonskin cancer and the second leading cause of cancer death among American men. Both incidence and mortality rates are increasing. The most clearly established risk factors for prostate cancer are advancing age and race: incidence increases rapidly with age, and the incidence in African-Americans is 30 percent higher than in US whites (1). A high fat diet and a history of prostate cancer in a close family relative have also been suggested as predictors of increased risk (2-11). Most previous studies demonstrating an association between family history and prostate cancer have not controlled for potential confounding by diet, however. Whittemore et al. (10) reported that dietary intake of saturated fat did not confound the relation between family history and prostate cancer risk. Age, race, and family history have been incorporated in published guidelines for prostate cancer screening in asymptomatic men (12, 13 Society guidelines, men with a positive family history warrant annual screening beginning at age 40, 10 years earlier than men with no family history (12).
Prostate cancer is the most common nonskin cancer and the second leading cause of cancer death among American men. Both incidence and mortality rates are increasing. The most clearly established risk factors for prostate cancer are advancing age and race: incidence increases rapidly with age, and the incidence in African-Americans is 30 percent higher than in US whites (1) . A high fat diet and a history of prostate cancer in a close family relative have also been suggested as predictors of increased risk (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . Most previous studies demonstrating an association between family history and prostate cancer have not controlled for potential confounding by diet, however. Whittemore et al. (10) reported that dietary intake of saturated fat did not confound the relation between family history and prostate cancer risk. Age, race, and family history have been incorporated in published guidelines for prostate cancer screening in asymptomatic men (12, 13) . According to the American Cancer Society guidelines, men with a positive family history warrant annual screening beginning at age 40, 10 years earlier than men with no family history (12) .
To test the hypothesis that a history of prostate cancer in a first degree relative increases the risk of prostate cancer, we analyzed data obtained in a population-based, matched case-control study among men younger than 70 years in Massachusetts.
MATERIALS AND METHODS Data collection
The data were collected from December 1992 through October 1994 in an ongoing study of prostate cancer. Potential cases were identified by monthly contact with the tumor registrar at 64 participating hospitals and by review of incident prostate cancer cases reported to the Massachusetts Cancer Registry. The attending physician of each potential case was contacted to confirm the diagnosis and to obtain permission to contact the patient. Cases were matched to other men (controls) living in the same town and in the same 5-year age group that had no history of prostate cancer.
Data were collected by nurse-interviewers using a structured questionnaire. Interviews were conducted by telephone; the nurse-interviewers were not told the case-control status of the men interviewed. The recorded data include descriptive factors (age, race, weight, height, years of education, occupation); past medical history (including history of vasectomy, screening for prostate cancer, and urologic symptoms); family medical history (including a history of prostate cancer in the father and up to five brothers); diet (using a semiquantitative food frequency questionnaire (14) ); use of tobacco and alcohol; exercise; and medication use. Information concerning the occurrence of prostate cancer in the sons of study subjects was not obtained. Data were collected concerning history, symptoms, and habits prior to a specified index date, which was the date of diagnosis for cases. For each control, the index date was set such that the interval between this date and the interview was equal to the corresponding interval for the matched case. For cases, we recorded the circumstances under which prostate cancer was detected (i.e., screening of asymptomatic men, in the course of medical evaluation of symptoms not suggestive of prostate disease, incidentally during transurethral resection of benign prostatic hypertrophy, or during evaluation of symptoms suggestive of prostate disease). Medical records of all prostate cancer cases were requested to confirm the diagnosis and determine clinical stage at diagnosis.
Cases. The cases were men less than 70 years of age residing in Massachusetts who had incident prostate cancer diagnosed or treated at participating hospitals or reported to the Massachusetts Cancer Registry. This analysis was conducted in the context of an ongoing study designed to test whether vasectomy increases the risk of prostate cancer. Because vasectomy is uncommon among very old men, the study was limited to men less than 70 years of age at diagnosis. Because of the large number of eligible cases, not all cases were interviewed; a representative sample was selected. All men who reported that their prostate cancer was detected because of new symptoms or incidentally during treatment for other conditions were interviewed, as was a 77 percent random sample of cases detected by screening. In the ongoing study, cases were excluded for the following reasons: physician refusal (12 percent), patient refusal (9 percent), not incident prostate cancer (1 percent), not resident of Massachusetts (3 percent), no telephone or telephone number unpublished (4 percent), not fluent in English (2 percent), concurrent illness that could impair recall (e.g., dementia; 1 percent), patient could not be interviewed within a year of diagnosis (7 percent), or death (2 percent). There were 563 cases in this analysis; the median age was 65 years, the median number of brothers was one, and 97 percent were white. Thirty-five cases were stage A, 235 cases were stage B, 102 cases were stage C, 29 cases were stage D, and 162 had incomplete or no information on stage.
Controls. Controls were men with no history of prostate cancer who were individually matched to cases on age (5-year category) and town of residence. Following the interview of each case, potential controls were selected from the published list of residents of the town where the case lived. The lists include the names of all residents older than 18 years, arranged alphabetically by street address within each precinct. Lists were reviewed in order, beginning with the street following that on which the case lived. Potential controls were the first 10 men in the same 5-year age category as the case. Men without published telephone numbers were excluded. Potential controls were screened by telephone to determine eligibility. Men were ineligible if they had a history of prostate cancer or if they reported chronic undiagnosed back, hip, or thigh pain or symptoms of prostatism without a recent prostate evaluation that was negative for prostate cancer. For each case, up to two eligible controls were scheduled for a later interview, which was conducted by another member of the study staff. At the outset of the study, we intended to enroll two controls per case. Because of greater than expected difficulty enrolling eligible controls and a larger than expected pool of cases, in January 1994, we changed our procedure and enrolled only one control per case. Initially selected controls were not enrolled for the following reasons: refusal (25 percent), error in town list (4 percent), not fluent in English (2 percent), history of prostate cancer or symptoms compatible with undiagnosed prostate cancer (6 percent), concurrent illness that could impair recall (1 percent), or subject judged unreliable by interviewer (one patient). There were 703 controls in this analysis; the median age was 64 years, the median number of brothers was one, and 98 percent were white.
Statistical analyses
The odds ratio (OR) was used to estimate the relative risk of prostate cancer among men whose fathers and brothers had prostate cancer compared with men who had no family history of prostate cancer. Confidence intervals were calculated using the test-based method, and the Mantel extension of the MantelHaenszel procedure was used to test for trend in ORs (15, 16) . Multivariate relative risk estimates were calculated using multiple conditional logistic regression analyses in which potential confounding factors (in-eluding the matching factors) were controlled (17) . Regression models included indicator terms for race, religion, number of brothers, vasectomy, body mass index (weight in kilograms/height in meters 2 ), dietary fat consumption, cigarette smoking, use of alcohol, number of physician visits in the previous year, and a term for first order interaction between diet and family history of prostate cancer. Crude and multivariate (matched) ORs were similar; only the former are presented in the text.
RESULTS
The distribution of potential confounding factors among cases and controls is shown in table 1. Cases tended to have a greater body mass index, consume more fat in their diet, and have more physician contact in the previous year than controls. Cases were also slightly more likely than controls to report past (but not current) use of alcohol.
The distribution of family history of prostate cancer (in fathers and brothers) among cases and controls is shown in table 2. Among the controls, 8.3 percent claimed a family history of prostate cancer; 5.3 percent reported that their father had prostate cancer, and 3.4 percent reported at least one brother who had this disease. Among the cases, 9.2 percent reported that their father had prostate cancer, and 7.1 percent reported that a brother was affected. Prostate cancer risk was increased among men who reported a history of the disease in either their father or at least one brother (OR = 2.3; 95 percent confidence interval (CI) 1.7-3.3). Among men whose father only had prostate cancer, the OR was 1.9 (95 percent CI 1.2-3.0); among men with one or more brothers who had prostate cancer and whose fathers did not have prostate cancer, the OR was 3.0 (95 percent CI 1.8-4.9). There were too few men whose father and at least one brother had prostate cancer for meaningful analysis. Risk increased as the number of affected relatives increased. Compared with men who had no affected relatives, the OR for men with a single relative with prostate cancer (85 cases, 51 controls) was 2.2 (95 percent CI 1.5-3.2); for men with two or more affected relatives (12 cases, five controls), the OR was 3.9 (95 percent CI 1.7-5.2).
The relation between family history of prostate cancer and the risk of prostate cancer stratified by age of the proband is shown in table 3. The association was strongest among men younger than 60 years (OR = .7); and among asymptomatic men, the OR was 3.4 (95 percent CI 2.0-5.7). We also examined the relation between family history and prostate cancer risk according to whether the subjects believed that genetic/familial factors influenced the risk of this cancer. Among men who believed that genetic factors influenced prostate cancer risk (27 cases and 15 controls), the OR was 6.2 (95 percent CI 1.4-28); among the remaining men, the OR was 2.0 (95 percent CI 1.4-2.9).
The relation between family history of prostate cancer and the risk of that disease stratified by dietary fat intake (expressed as the proportion of calories from fat, in tertUes) is shown in table 7. The point estimate was elevated in each category of fat intake; the ORs ranged between 1.7 and 3.1. There was no significant interaction between fat intake and family history of prostate cancer.
DISCUSSION
A number of earlier studies have suggested that prostate cancer has a familial pattern. In Utah Mormons, Woolf (4) observed that the risk of prostate cancer was approximately threefold greater among first degree relatives of patients with the disease than among the relatives of age-matched controls. Among men younger than 62, Meikle et al. (5) found a fourfold greater risk of prostate cancer among brothers of prostate cancer cases than among their brothers-inlaw. Cannon et al. (6) computed a coefficient of kinship for a number of cancers using data from the Utah Cancer Registry and the Utah Mormon Genealogical Database. Prostate cancer had a higher degree of familiality than either breast or colon cancer-two canAm J Epidemiol Vol. 144, No. 11, 1996 cers with well-recognized familial tendencies. In a recent study involving 691 prostate cancer cases and the male relatives of their wives, Steinberg et al. (7) observed an increased risk of prostate cancer among men whose first or second degree relatives also had prostate cancer. The odds ratio for men with an affected second degree relative was 1.7 (95 percent CI 1.0-2.9); for men with an affected first degree relative it was 2.0 (95 percent CI 1.2-3.3); and among men with both first and second degree relatives affected, it was 8.8 (95 percent CI 2.8-28). Risk also increased as the number of affected first degree relatives increased. Using a Cox proportional hazards analysis of these same data, Carter et al. (8) reported that young age at onset of prostate cancer in the proband and multiple affected family members were associated with the greatest increase in prostate cancer risk. In a populationbased case-control study in US blacks and whites, Hayes et al. (9) observed an OR of 3.0 (95 percent CI 2.0-5.0) overall. Risk was higher among men whose brothers had prostate cancer (OR = 5.3) but did not vary by race or age at diagnosis. Whittemore et al. (10) reported an OR of 2.5 (95 percent CI 1.9-3.3) in a matched case-control study involving black, white, and Asian men. Risk did not vary by ethnicity or age. In a cross-sectional study of a consecutive series of men referred to a urology service for prostate cancer detection, Aprikian et al. (11) found a positive family history of prostate cancer more commonly among men with prostate cancer than among controls (OR = 1.7; 95 percent CI 1.3-2.1). Cases with a positive family history were similar in age to cases without this history, but the effect of race on the association was not evaluated.
In addition to genes, family groups may share dietary habits and other behaviors that influence prostate cancer risk. Most earlier studies reporting a familial risk of prostate cancer did not have information on diet and, therefore, could not separate genetic and dietary effects on prostate cancer risk. The present report includes information on diet. Our results are consistent with earlier reports and reinforce the observation by Whittemore et al. (10) that diet does not materially confound the relation between family history and prostate cancer. We did not have dietary information for the relatives of our cases or controls, and we could not determine to what extent common dietary habits within families may have contributed to the differences in prostate cancer risk observed between families. Detailed dietary information from all male family members would help to clarify this issue. In addition to diet, we controlled for the effects of the principal risk factors for prostate cancer (i.e., age, race) and other potential confounding factors (e.g., tobacco and alcohol use, vasectomy) in our analysis.
To minimize information bias, we had specially trained nurses collect data using a structured questionnaire in an identical fashion for cases and controls. Interviews were conducted without prior knowledge of disease status of the men involved, and neither the study subjects nor the interviewers were aware of the specific hypothesis being tested. Information bias could still account for the observed association if a greater proportion of men with recently diagnosed prostate cancer than their neighbors recalled a history of prostate cancer among family members, even if the actual incidences of prostate cancer in these families were similar. The similarity of our findings to those of previous studies that used methods less subject to information bias is evidence against material information bias in our data (4, 5) . That the association was present among the subgroup of subjects who did not consider prostate cancer to be a genetically determined disease is also reassuring.
Detection bias could account for or contribute to the observed association if men with a positive family history were more likely than men without such a history to participate in prostate cancer screening programs or to seek early detection of prostate cancer. The slightly stronger association among men with no history of urologic symptoms is consistent with such an effect. However, a positive relation between family history and prostate cancer risk was also observed among men (cases and controls) with a history of urologic symptoms and was present for subsets of cases who reported that they had come to diagnosis because of symptoms and for those with advanced stage disease (stages C and D). Analyses involving these latter cases, men with advanced disease, are believed to be less subject to detection bias because diagnosis is likely to be obligatory among these cases.
Because of the very small proportion of minority men in these data, the observations may apply only to white men. It is a limitation of these data that we did not directly validate the prevalence of prostate cancer among male relatives of our study subjects. However, the rates observed are comparable with those reported in earlier studies and are consistent with rates predicted by data not dependent on subject recall (5, 7, 10, 11) .
These data provide additional evidence that familial factors are associated with the risk of prostate cancer, an association that remains after controlling for the potential confounding effects of other factors, including diet. As in some of the earlier studies, we observed that risk increased as the number of affected family members increased, and risk was greatest among the youngest men studied. Also, we found risk to be Am J Epidemiol Vol. 144, No. 11, 1996 Family History and Prostate Cancer Risk 1047 inversely related to age at diagnosis of prostate cancer in affected family members. Even among the oldest men in this study (65-69 years of age), a history of prostate cancer diagnosed in a family member younger than 65 was associated with a doubling in prostate cancer risk. Each of these observations is compatible with the effects of a heritable factor that predisposes men with the factor to prostate cancer.
